SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-048850
Filing Date
2015-02-13
Accepted
2015-02-13 11:11:00
Documents
2
Group Members
BML GENERAL PARTNER LTDROSETTA CAPITAL LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G d871054dsc13g.htm SC 13G 75239
2 EX-99.1 d871054dex991.htm EX-99.1 4028
  Complete submission text file 0001193125-15-048850.txt   80772
Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100
Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88394 | Film No.: 15610987
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEW BROAD STREET HOUSE 35 LONDON X0 EC2M 1NH
Business Address NEW BROAD STREET HOUSE 35 LONDON X0 EC2M 1NH 44 0 20 7194 8080
Rosetta Capital I, LP (Filed by) CIK: 0001633682 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G